Heinrich P Mattle. Show Affiliations »
Abstract
Entities: Species
Mesh: See more » Drug Administration RoutesFibrinolysis/physiologyFibrinolytic Agents/administration & dosageFibrinolytic Agents/therapeutic useHeparin/therapeutic useHumansRandomized Controlled Trials as TopicRecombinant Proteins/therapeutic useStroke/drug therapyThrombolytic Therapy/methodsTissue Plasminogen Activator/administration & dosageTissue Plasminogen Activator/therapeutic useTreatment OutcomeUrokinase-Type Plasminogen Activator/therapeutic use
Substances: See more » Fibrinolytic AgentsRecombinant ProteinsHeparinTissue Plasminogen ActivatorUrokinase-Type Plasminogen Activatorsaruplase
Year: 2007 PMID: 17540964 DOI: 10.1161/STROKEAHA.107.487124
Source DB: PubMed Journal: Stroke ISSN: 0039-2499 Impact factor: 7.914